Dominick Gatto

Chief Executive Officer @Cyduct Diagnostics, Inc

Westport, CT, US

CYduct Diagnostics, Inc. develops, produces, and markets medical products for the assessment, identification, diagnosis and ultimately treatment of early-stage breast disease. CYduct’s goal is to provide personalized risk assessment tools which will help identify precancerous and cancerous lesions within the mammary ducts. CYduct technology platforms of breast care products are being developed to assess, detect, monitor and eventually treat identifiable changes that distinguish variations in breast health. CYduct is committed to providing both women and clinicians with noninvasive and minimally invasive technology that will continue to accelerate the intraductal evolution and improvement in breast care to: 1) assess breast health risk, 2) monitor breast health, 3) identify the need for increased personalized risk surveillance and 4) provide the tools to monitor, diagnose and finally treat breast disease through direct visual examination (Breast Endoscopy) within the ductal system of the breast.